A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Clinical trial NCT07013474 · RECRUITING

Trial details

NCT number: NCT07013474
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Infection

Start date: 2025-07-14
Primary completion: 2027-09-27
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.